No conviction changes recorded
Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
93.6% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
1.9%/yr
±3.5% · revenue growth to justify current price
FCF-Based Reverse DCF
6.1%/yr
±2.7% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockNo analysis yet
No analysis yet
DOC FY2025 10-K: Merged with PRT (March 2024), now 689-property diversified healthcare REIT. .36B combined OM+Lab NOI, 34 senior housing communities planned for Janus Living IPO separation (H1 2026). ...